When: Formal buyback resumption disclosure from management

Then: Re-enter 50% position size; evaluate residual on price reaction

SELL — but with trim at or below five percent of portfolio, wider collar strikes with puts deeper to $350–360, and full cash retention until at least two of three unresolved catalysts resolve (commercial cost trend, IRS exposure, buyback resumption); re-entry gated on 50 SMA reclaim with confirmation, cost trend stabilization, or buyback resumption.

• Q4 2025 EPS was $0.01 versus Q1 2026 EPS of $6.90 — recovery is comparison to depressed base, not proof of normalized earnings power
• Zacks triple Strong Buy is lagging data point after eighty percent rally off bottom; insider buyback suspension for three consecutive quarters is a more reliable negative signal
• Trim should be five percent or below (lower end of aggressive's five to ten percent range) until at least one catalyst goes right
• Collar puts should be $350–360 zone rather than $370–380; 200 SMA support sits at $346 area, making lower put strike more protective
• Fourteen percent drawdown to 200 SMA is still a real loss; confirmed break of 200 SMA opens up fifty-plus percent move similar to Q4 2025
• Conservative move is trim, hold meaningful cash, and wait for defined re-entry triggers — not redeploy immediately into cleaner names
• Jackson Hole event risk tomorrow with hawkish surprise potential; stock technically extended below all short-term averages
• Redeployment gates: need visibility on at least two of three — commercial cost trend stabilization, IRS exposure clarity, buyback resumption

→ vs neutral: HOLD thesis is more dangerous than it looks; long-term trend intact and recovery narrative are precisely conditions under which the next leg down catches the most capital — Q4 2025 demonstrated this risk

→ vs aggressive: Benchmark or below trim still leaves too much exposure; five percent or below is appropriate given frozen buyback, unresolved IRS adjustment, and deteriorating commercial cost trends

→ vs aggressive: Collar puts at $370–380 protect to mid-range but not to actual structural damage level; $350–360 puts necessary given 200 SMA at $346

→ vs aggressive: 'Asymmetry' and 'probability asymmetry' language can lull risk committees into underestimating true downside; prefer strict position caps, hard stops, and defined outcomes over narrative conviction

→ vs neutral: Zacks triple Strong Buy is not a confirmation signal — it caught up to price after eighty percent rally; buyback suspension is what management is actually doing with capital

→ vs aggressive: Redeployment into cleaner setups should wait for re-entry triggers, not market optimism; cash is a position until the risks trimmed for actually resolve

TRIM to 5-7% portfolio weight with collar; re-entry on one confirmed trigger

• Trim is warranted but magnitude should be 5 to 7 percent, not the aggressive's 10 percent or conservative's below 5 percent
• Dividend at 2.31% ($9 per share annually) is protected by $24 billion in trailing FCF and represents meaningful cash flow carry for accounts with structural UNH mandates
• Redeployment alternatives (healthcare peers, defensive staples, Treasuries) all carry similar or elevated risks—trimming UNH doesn't solve the redeployment problem
• Q1 EPS of $6.90 reflects structural operational improvements (MA profitability pivot, behavioral coaching expansion, cost controls) beyond just easy rebound from Q4 2025 operational event
• Forward PE of 17.6x becomes 21.9x on probability-weighted EPS, but 21.9x is in line with UNH's 10-year average multiple of 22-24x—fairly valued with execution risk, not structurally overvalued
• Bear thesis has moderate negative skew near-term but bull thesis has wider range of favorable outcomes beyond one to three months
• Sell calls at 430 to 440 to fund puts at 370 to 380—wider than conservative's 350-360 puts which break collar economics given elevated but not extreme IV in high 20s to low 30s
• One confirmed catalyst (any one of sustained 50 SMA break at 413, buyback announcement, or Q2 confirmation) is sufficient for re-entry—conservative's two-of-three requirement creates paralysis risk

→ vs aggressive: Treating the 2.31% dividend as a 'rounding error' and 'emotional comfort' undervalues $9 annual per-share dividend funded roughly twelve times over by $24 billion in trailing FCF; dividend carry matters for pensions, healthcare mandates, and tax-deferred accounts with concentration limits

→ vs aggressive: Listed eight catalysts for bull case but three (Q2 confirmation, cost stabilization, MA margin expansion) are the same underlying question—if Q2 prints clean, all three resolve simultaneously; inflating difficulty rhetorically undermines asymmetry argument

→ vs aggressive: 'Trim and redeploy' framing ignores that healthcare peers (ELV, CI, HUM, CNC, MOH) face same 9.5% Aon employer cost trend, defensive staples are at multi-year valuation extremes, and 10-year Treasury at 4%+ offers no duration upside; redeployment problem is unsolved

→ vs conservative: Puts at 350-360 change collar economics meaningfully; to fund protection at those strikes against $395 stock with IV in high 20s to low 30s requires significant premium, breaking the 'premium-neutral' structure and negating IV monetization benefit; put spread or equity trim may be cleaner

→ vs conservative: Two-of-three re-entry framework creates paralysis risk—Q2 earnings print mid-July and if cost trends improve, stock will be at 440-460 by the time data confirms what market has already priced in; waiting for confirmation means missing the move

→ vs conservative: Treating Q1 EPS of $6.90 as just recovery from depressed base underweights structural changes: medical cost spike and cyberattack aftershocks in Q4 2025 were operational events addressed by MA profitability pivot, behavioral coaching expansion, and new cost controls—not noise